« New NYLJ Article: "When to Get Counsel Involved in Audits, Investigations and Self-Disclosures" | Main | FDAAA requirements update: drug safety, clinical trials database »

CDT highlights its concerns: the US Supreme court case Sorrell v IMS Health Inc.

3/22- CDT's Health Privacy Project published a memo (5pp) on the US Supreme Court case Sorrell V. IMS Health Inc. (arguments scheduled to be heard on April 26)-CDT focuses on nuances in understanding privacy in its discussion of 2 aspects of this case 1. the valid distinctions between personally identifiable data and 'de-identified' data, and 2. the claim regarding doctors having a 'privacy' right in their drug prescribing practices. (1) The Question Presented on the SCOTUS case docket indicates that the law at issue in this case, Vermont's Prescription Confidentiality Law, affords prescribers the right to consent before info linking them to prescriptions for particular drugs can be sold or used for marketing. It also provides a helpful sketch showing the context of the generation of and use of such data use and then frames the Question Presented. The list of Amicus briefs is impressive, promising an impressive read on the subject.(2)

(1)http://www.cdt.org/paper/memo-sorrell-v-ims-health-inc-supreme-court-case-requires-nuanced-understanding-privacy Deven McGraw is the Director of the Health Privacy Project at CDT. The Project is focused on developing and promoting workable privacy and security protections for electronic personal health information.
(2)http://www.supremecourt.gov/Search.aspx?FileName=/docketfiles/10-779.htm

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

This page contains a single entry from the blog posted on April 6, 2011 2:40 PM.

The previous post in this blog was New NYLJ Article: "When to Get Counsel Involved in Audits, Investigations and Self-Disclosures".

The next post in this blog is FDAAA requirements update: drug safety, clinical trials database.

Many more can be found on the main index page or by looking through the archives.